Lower risk Drug recall · FDA · Published October 1, 2019

Sato Pharmaceutical Motion Sickness Tablets Recall: Subpotent Drug Risk

Sato Pharmaceutical recalls 25mg meclizine tablets due to subpotent drug levels. Affected products have specific lot numbers and expiration dates. Consumers should contact the company for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0323-2020Drug Sato Pharmaceutical ›

Lower-risk recall

Subpotent Drug

Take action

Contact the company

Recalling firmSato Pharmaceutical Inc.20695 S Western Ave Ste 240 · Torrance, CA 90501-1834

✎ GovInfoNow plain-language explainer

Sato Pharmaceutical is recalling 25 mg motion sickness tablets that may not contain the full amount of active ingredient. This could lead to the medication being less effective than intended. Read more at govinfonow.com/recall/37872-sato-pharmaceutical-motion-sickness-tablets-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37872-sato-pharmaceutical-motion-sickness-tablets-recall-subpotent-drug-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0323-2020

Cite this page

“Sato Pharmaceutical Motion Sickness Tablets Recall: Subpotent Drug Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37872-sato-pharmaceutical-motion-sickness-tablets-recall-subpotent-drug-risk. Based on FDA recall #D-0323-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0323-2020%22&limit=1).

The FDA announced on Oct. 1, 2019, that Sato Pharmaceutical Inc. voluntarily recalled Motion Sickness (meclizine hydrochloride) 25 mg tablets due to subpotent drug risks. The recall affects 210,744 units distributed nationwide.

How to tell if you have it

Sato Pharmaceutical Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box
UPC: 050428345535
Lot codes: TXWP, TXTP, AXTZ, AXNP, AXBC, ZXWW
Expiration dates: Jul 2020, Mar 2021, Jul 2021, Oct 2021, Dec 2021

The hazard

The FDA classified the recall as Class III because the tablets are subpotent. This means the amount of active ingredient is less than what is labeled.

Context

GovInfoNow's records show Sato Pharmaceutical Inc. has 3 other recalls on record since 2017-02-16. Other recent recalls of similar products include Yunker Energy & Health Herbal Supplement with Vitamins Recall (2026-03-12), Sato Pharmaceutical Recalls Botanical Laxative Tablets Due to Subpotent Sennosides (2019-10-01), and Sato Pharmaceutical Inc. recalls SATO CLEAR Redness Reliever Eye Drops (2017-02-16). Other recent recalls of similar products include Sato Pharmaceutical INON ACE Antacid Tablets Recall (2025-12-19), Unichem busPIRone 5mg Tablets Recall (2026-04-13), and Major Pharmaceuticals Levothyroxine Tablets Recall (2026-07-13).

How to tell if you have this one

Check for the product name 'Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box'. Look for lot numbers TXWP, TXTP, AXTZ, AXNP, or AXBC with specific expiration dates.

Brand
Sato Pharmaceutical
Product
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S
Category
Drug

FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class III
Status
Terminated
Distribution
Nationwide within the United States, Guam and Saipan

Recall number	Product, codes & lots	Quantity	NDC
D-0322-2020	Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603; Lot #: TXWW, TXTW, Exp. date Dec 2019; AXPS, AXLS, AXBS AXNS, Exp. date Oct 2021; AXZL, AXAL, AXTL, AXWL, Exp. date Jun 2021.	21,864 units	—
D-0323-2020	Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535; Lot #: TXWP, TXTP, Exp. date Jul 2020; AXTZ, Exp. date Mar 2021; AXNP, Exp. date Jul 2021; AXBC, Exp. date Oct 2021; ZXWW, Exp. date Dec 2021	210,744 units	59779-534-01, 0504283455
D-0324-2020	WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,; Lot #: a) AXWA, Exp. date Feb 2021; AXAB, Exp. date May 2021; AXLK, Exp. date Nov 2021; b) AXZP, Exp. date Jul 2021	a) 112,104 units b) 24,696 units	0363-1407-01, 0363-1407-02
D-0325-2020	Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946; Lot #: AXTK, AXAK, AXZK, AXNK, AXBK, AXLK, AXPK, AXCK, Exp. Date Nov 2021	39,504 units	—

Based on the official FDA remedy

What to do — step by step

Check Product Details
Identify the lot number and expiration date on the packaging to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide within the United States, Guam and Saipan” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

Oct 1, 2019Firm started the recall
Nov 13, 2019FDA classified it Class III
Nov 20, 2019Published in FDA’s Enforcement Report
Aug 18, 2020FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sato Pharmaceutical recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/37872-sato-pharmaceutical-motion-sickness-tablets-recall-subpotent-drug-risk">Sato Pharmaceutical Motion Sickness Tablets Recall: Subpotent Drug Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0323-2020 (October 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0323-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.